380 related articles for article (PubMed ID: 31255650)
1. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
[TBL] [Abstract][Full Text] [Related]
2. Human Pluripotent Stem Cells in Neurodegenerative Diseases: Potentials, Advances and Limitations.
Kolagar TA; Farzaneh M; Nikkar N; Khoshnam SE
Curr Stem Cell Res Ther; 2020; 15(2):102-110. PubMed ID: 31441732
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory effects of stem cells: Therapeutic option for neurodegenerative disorders.
Caprnda M; Kubatka P; Gazdikova K; Gasparova I; Valentova V; Stollarova N; La Rocca G; Kobyliak N; Dragasek J; Mozos I; Prosecky R; Siniscalco D; Büsselberg D; Rodrigo L; Kruzliak P
Biomed Pharmacother; 2017 Jul; 91():60-69. PubMed ID: 28448871
[TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
Gao A; Peng Y; Deng Y; Qing H
Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
[TBL] [Abstract][Full Text] [Related]
5. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
Pen AE; Jensen UB
Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
[TBL] [Abstract][Full Text] [Related]
6. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cell-based treatment for neurodegenerative diseases.
Kim SU; Lee HJ; Kim YB
Neuropathology; 2013 Oct; 33(5):491-504. PubMed ID: 23384285
[TBL] [Abstract][Full Text] [Related]
8. Utilising Induced Pluripotent Stem Cells in Neurodegenerative Disease Research: Focus on Glia.
Albert K; Niskanen J; Kälvälä S; Lehtonen Š
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919317
[TBL] [Abstract][Full Text] [Related]
9. Induced pluripotent stem cells (iPSCs) as game-changing tools in the treatment of neurodegenerative disease: Mirage or reality?
Yousefi N; Abdollahii S; Kouhbanani MAJ; Hassanzadeh A
J Cell Physiol; 2020 Dec; 235(12):9166-9184. PubMed ID: 32437029
[TBL] [Abstract][Full Text] [Related]
10. Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer's Disease and Parkinson's Disease.
Xu Y; Wang S; Zhu P
Curr Stem Cell Res Ther; 2023; 18(2):154-162. PubMed ID: 35473516
[TBL] [Abstract][Full Text] [Related]
11. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.
Jung YW; Hysolli E; Kim KY; Tanaka Y; Park IH
Curr Opin Neurol; 2012 Apr; 25(2):125-30. PubMed ID: 22357218
[TBL] [Abstract][Full Text] [Related]
12. Introduction for Stem Cell-Based Therapy for Neurodegenerative Diseases.
Han F; Lu P
Adv Exp Med Biol; 2020; 1266():1-8. PubMed ID: 33105491
[TBL] [Abstract][Full Text] [Related]
13. Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases.
Payne NL; Sylvain A; O'Brien C; Herszfeld D; Sun G; Bernard CC
N Biotechnol; 2015 Jan; 32(1):212-28. PubMed ID: 24815224
[TBL] [Abstract][Full Text] [Related]
14. Induced pluripotent stem cells and Parkinson's disease: modelling and treatment.
Xu X; Huang J; Li J; Liu L; Han C; Shen Y; Zhang G; Jiang H; Lin Z; Xiong N; Wang T
Cell Prolif; 2016 Feb; 49(1):14-26. PubMed ID: 26748765
[TBL] [Abstract][Full Text] [Related]
15. Human embryonic stem cell therapies for neurodegenerative diseases.
Tomaskovic-Crook E; Crook JM
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):440-8. PubMed ID: 21495960
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders.
Smith DK; He M; Zhang CL; Zheng JC
Prog Neurobiol; 2017 Oct; 157():212-229. PubMed ID: 26844759
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling.
Beghini DG; Kasai-Brunswick TH; Henriques-Pons A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397069
[TBL] [Abstract][Full Text] [Related]
18. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
Machairaki V
Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in iPSC technologies involving cardiovascular and neurodegenerative disease modeling.
Csöbönyeiová M; Danišovič Ľ; Polák Š
Gen Physiol Biophys; 2016 Jan; 35(1):1-12. PubMed ID: 26492069
[TBL] [Abstract][Full Text] [Related]
20. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
